CMAC 2008; 10(4) | CMAC

CMAC 2008; 10(4)

Invasive mycoses are the substantial cause of morbidity and mortality in immunocompromised children. The prevalence of invasive mycoses …
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):292-304
PDF

Community-acquired pneumonia (CAP) is the 4-8th leading killer of people worldwide and the most leading cause of death from infections …
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):305-321
PDF

Carbapenems are the most appropriate antimicrobials for empiric and pathogen-directed monotherapy in most severe and life-threatening …
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):322-332
PDF

Objective. To determine in vitro activity of antimicrobials against S. aureus isolated from ICU patients in different regions of …
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):333-344
PDF

Purpose of the study. From 2003 till 2008 eight research centers in Russia from Ekaterinburg, Irkutsk, Krasnodar, Novosibirsk, Moscow, …
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):345-354
PDF

Retrospective study of antifungal consumption in 1029-bed hospital during the 2004–2006 was performed. Defined daily dose (DDD) per 100 …
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):355-361
PDF

To assess prevalence of antibodies to spirochetes of Borrelia burgdorferi sensu lato complex among blood donors in Moscow region, a …
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):362-367
PDF

The aim of the study was to determinate the structure of bacterial pathogens and their antimicrobial resistance in adult patients with …
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):368-380
PDF